Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Eur Radiol. 2015 Apr 8;25(9):2779–2788. doi: 10.1007/s00330-015-3677-4

Table 2.

Patient demographics

All patients (n=74) Patients treated with LC Bead (n=40) Patients treated with BeadBlock (n=34) p-value
Age (years); median (range) 67 (29–87) 67 (29–86) 68 (50–87) 0.470
Gender >0.999
 Male 60 (81) 32 (80) 28 (82)
 Female 14(19) 8 (20) 6 (18)
Liver Disease >0.999
 Hepatitis B virus 15 (20) 8 (20) 7 (21)
 Hepatitis C virus 24 (33) 13 (33) 11 (32)
 Other 35 (47) 19 (47) 16 (47)
Child-Pugh Class 0.286
 A 65 (88) 37 (92) 28 (82)
 B 9 (12) 3 (8) 6 (18)
Serum α-fetoprotein; median (range) 23.9 (1.7– 51122.8) 31.4 (1.7– 22506.2) 18.9 (1.7– 51122.8) 0.276
 ≤ 200 ng/ml 52 (71) 28 (70) 24 (71) >0.999
 > 200 ng/ml 21 (28) 11 (28) 10 (29)
 unknown 1 (1) 1 (2) 0 (0)
Total number of lesions; median (range) 2 (1–6) 2 (1–6) 1.9 (1–4) 0.723
Distribution of lesions >0.999
 Solitary 36 (49) 19 (48) 17 (50)
 Multifocal 38 (51) 21 (52) 17 (50)
Lesions only in left liver 16 (21) 9 (22) 7 (21)
Lesions only in right liver 39 (53) 20 (50) 19 (56)
Lesions in both liver lobes 19 (26) 11 (28) 8 (23)
Number of follow up CTs >0.999
 1 74 (100) 40 (54) 34 (46)
 2 70 (95) 37 (93) 33 (97)
*

Unknown serum α-fetoprotein was not included in the test.